A second gene expression profiling study of ADH synchronous with cancer (DCIS/IDC) (n = 31, eight with ADH) showed that significant alterations are already present in ADH and maintained in DCIS and IDC [75]. This evidence concerns the gene AVP and ductal breast carcinoma in situ.